Press "Enter" to skip to content

Wockhardt gets USFDA nod for generic cancer drug

Wockhardt’s Imatinib Mesylate tablets are a generic version of Gleevec, marketed in USA and other countries by Novartis.

Original source: https://health.economictimes.indiatimes.com/news/pharma/wockhardt-gets-usfda-nod-for-generic-cancer-drug/67627237?utm_source=RSS&utm_medium=ETRSS

Also Read:   FDA approves Global Blood Therapeutics sickle cell disease drug